Document:

Definition of Change of Control

 Exhibit 10. A 
  
 Atlantic Tele-Network,Inc. 
 Compensation Committee Rule 
 Updated: May     , 2005 
  
 Atlantic Tele-Network, Inc. 2005 Restricted Stock and Incentive Plan

 Definition of “Change of Control” 
  
 For the purpose of The 2005 Restricted Stock and Incentive Plan of Atlantic Tele-Network, Inc. (the “Company”), a
“change of control” shall be deemed to have occurred if after the date hereof 
  

	 	(i)	a report on Schedule 13D or Schedule 13G shall be filed with the Securities and Exchange Commission pursuant to Section 13(d) of the Act disclosing that any person other than the
Company or any employee benefit plan sponsored by the Company, is the beneficial owner (as the term is defined in Rule 13d-3 under the Act) directly or indirectly, of thirty percent or more of the total voting power represented by the Company’s
then outstanding voting securities (calculated as provided in paragraph (d) of Rule 13d-3 under the Act in the case of rights to acquire voting securities); or 

  

	 	(ii)	any person, other than the Company or any employee benefit plan sponsored by the Company, shall purchase shares pursuant to a tender offer or exchange offer to acquire any Voting
Securities of the Company (or securities convertible into such Voting Securities) for cash, securities or any other consideration, provided that after consummation of the offer, the person in question is the beneficial owner directly or indirectly,
of thirty percent or more of the total voting power represented by the Company’s then outstanding voting securities (all as calculated under clause (i)); or 

  

	 	(iii)	the stockholders of the Company shall approve (A) any consolidation or merger of the Company in which the Company is not the continuing or surviving corporation (other than a merger
of the Company in which holders of Common Shares of the Company immediately prior to the merger have the same proportionate ownership of common Shares of the surviving corporation immediately after the merger as immediately before or a merger
effected pursuant to Section 251(g) of the Delaware General Corporation Law), or pursuant to which common stock of the Company would be converted into cash, securities or other property, or (B) any sale, lease exchange or other transfer (in one
transaction or a series of related transactions) of all or substantially all the assets of the Company; or 

  

	 	(iv)	there shall have been a change in the composition of the Board of Directors of the Company at any time during any consecutive twenty-four month period such that “continuing
directors” cease for any reason to constitute at least a 70% majority of the Board. For purposes of this clause, “continuing directors” means those members of the Board who either were directors at the beginning of such consecutive
twenty-four month period or were elected by or on the nomination or recommendation of at least a 70% majority of the then-existing “continuing directors.” 

  
 So long as there has not been a “change of control” within the meaning of clause (iv), the Board of Directors may
adopt by a 70% majority vote of the “continuing directors” a resolution to the effect that an event described in clauses (i) or (ii) shall not constitute a “change of control.” 
  
 Notwithstanding the foregoing, no “change of control” shall have
occurred or be deemed to be continuing, during such time as Cornelius B. Prior, Jr., his spouse or his lineal descendents, directly or in trust for their benefit, shall have voting control of (a) 50% or more of the outstanding shares entitled to
vote, or (b) 35% or more of the outstanding shares entitled to vote at a time when no other shareholders described in (i) above own in the aggregate 35% or more of the outstanding shares entitled to vote.Amended and Restated Termination Agreements for Executive Officers

 Exhibit 10.1 
  
 AMENDMENT, WAIVER AND RELEASE AGREEMENT 
  
 THIS AGREEMENT, made this «Execution_DAY» day of «Execution_MONTH», 2005, by and between Novoste
Corporation, a Florida corporation, with its principal offices at 4350 International Boulevard, Norcross, Georgia 30093 (the “Company”) and «FirstName» «LastName» (the “Executive”) residing at
«Address1»«Address2», «City», «State» «PostalCode». 
  
 WHEREAS, the Company and the Executive entered into an Amended and Restated Termination Agreement (the “Termination Agreement”) on or about the
«Termination_Agmt_DAY» day of «Termination_Agmt_MONTH», «Termination_Agmt_YEAR», whereby the Company agreed to provide certain benefits to the Executive in the event that there was a change of control during the
term of the Termination Agreement, as such term was defined in the Termination Agreement; and 
  
 WHEREAS, the management and Board of Directors of the Company are engaged in the analysis and consideration of certain strategic alternatives for the Company, which strategic alternatives may result in a change in
control, as such term is defined in the Termination Agreement; and 
  
 WHEREAS, in order to successfully complete the transactions being reviewed and considered by the Company it will be necessary to reduce the amount of money paid to executives in the event of a change in control; and 
  
 WHEREAS, in the event that a strategic transaction is not completed by the
Company, it is the belief of the Executive that s/he may, therefore, not have the ability or opportunity to be paid any amounts of compensation as a change of control payment, and would instead, in the event of her/his termination by the Company,
receive a substantially smaller amount as severance pay; and 
  
 WHEREAS, the Executive desires to amend the Termination Agreement, waive a portion of her/his change in control payment thereunder and release the Company from its obligation under the Termination Agreement for the specific purpose of
enabling the Company to negotiate a strategic transaction with Best Medical International, Inc. (“Best”) or Eckert & Ziegler, AG (“Eckert & Ziegler”), in the form of any acquisition by Eckert & Ziegler of a
majority of the Company’s common stock through a tender offer, or the acquisition by Best of the assets of the Company’s vascular brachytherapy business, or with ONI Medical Systems, Inc. (“ONI”), in the form of the
Company’s acquisition, by merger, of ONI, (collectively, the “Transaction”). 
  
 NOW, THEREFORE, in order to assure the Company that it will have the continued dedication of the Executive, notwithstanding the possibility, threat or occurrence of a bid to takeover the Company, or other change of
control of the Company, and to assure the Company that it has the power to negotiate a Transaction with certain strategic partners so as to maximize the potential success of such Transaction, and to induce the Executive to continue to cooperate with
and assist, as needed, the management 

 
of the Company, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the Executive and the Company,
the Company and the Executive agree as follows: 
  

	 	1.	That if the transaction or event that constitutes the “Change in Control” (as defined in the Termination Agreement) that triggers the Executive’s right to receive
amounts pursuant to Section 4 of the Termination Agreement is one of the Transactions, then the Termination Agreement shall be, and is hereby amended as follows: 

  

	 	a.	Paragraph 3(g) of the Termination Agreement shall be amended as follows: 

  

	 	3.(g)	“Service Multiple” shall mean 1.75. 

  

	 	b.	Paragraph 4(a)(ii) of the Termination Agreement shall be deleted in its entirety. 

  

	 	c.	Paragraph 4(a)(iii) of the Termination Agreement shall be amended as follows: 

  

	 	4.(a)(iii)	in lieu of any further base salary payments to the Executive for periods subsequent to the date that the termination of the Executive’s employment becomes effective, the
Company shall pay as severance pay to the Executive a lump-sum cash amount equal to the Service Multiple (as defined in Section 3(g), as amended by the terms of this Agreement, Waiver and Release Agreement) times the Executive’s Annualized
Salary. The severance pay due pursuant to this section shall be the total amount of severance pay payable to Executive subsequent to a change of control and shall be in lieu of any other severance payment granted or promised to Executive under any
other agreements or policies of the Company, and, in the event Executive has been paid any severance payment prior to the time the severance pay under this section 4(a)(iii) becomes due and payable, the previous payment shall be deducted from the
severance pay due hereunder. 

  

	 	d.	The paragraph reference “4(a)(ii)” shall be deleted from the fifth line of Paragraph 4(d). 

  

	 	2.	All other terms, provisions, conditions and obligations of the Termination Agreement, not specifically amended hereby, shall remain in full force and effect.

	 	3.	The Executive hereby expressly releases the Company from obligations to the Executive which were eliminated, terminated or otherwise modified by the terms of this Amendment, Waiver
and Release Agreement. 

  

	 	4.	The parties hereby affirm and acknowledge that the amendments, waivers, and releases set forth, established by, and contained herein are for the limited purpose of enabling the
Company to negotiate and enter into the Transaction specifically described above, and for no other purpose or transaction, and, in the event that the Transaction is not consummated by December 31, 2005, this Amendment, Waiver and Release Agreement
shall automatically terminate and be of no further force or effect thereafter. 

  

	 	5.	This Amendment, Waiver and Release Agreement is irrevocable to the fullest extent provided under the laws of the State of Georgia and may not be amended or otherwise modified
without the prior written consent of the Company. 

  

	 	6.	This Amendment, Waiver and Release Agreement shall be governed by and construed in accordance with the laws of the State of Georgia. 

  
 IN WITNESS WHEREOF, the Parties have caused this Amendment, Waiver and
Release Agreement to be executed this «Execution_DAY» day of «Execution_MONTH», 2005. 
  

			
	NOVOSTE CORPORATION
		
	By:	 	  

	Its:	 	  

	
	EXECUTIVE
	
	

	 Name:
	 	«FIRSTNAME»«LASTNAME»

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]